Capstone Investment Advisors
IART icon

Capstone Investment Advisors’s Integra LifeSciences IART Stock Holding History

Capstone Investment Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,312
Closed -$518K – 769
2017
Q1 		$518K Buy
+12,312
New +$526K 0.01% 591
2016
Q4 		– Sell
-7,800
Closed -$321K – 1020
2016
Q3 		$321K Sell
7,800
-1,400
-15% -$58.7K 0.01% 590
2016
Q2 		$366K Buy
+9,200
New +$331K 0.01% 531

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capstone Investment Advisors's IART Position: Q2 2017 in Review

Capstone Investment Advisors sold out of Integra LifeSciences (IART) in Q2 2017, closing a stake of 12,312 shares — an estimated $518K sold.

Capstone Investment Advisors first reported a position in IART in Q2 2016 and held it in 3 quarters. The position peaked at $518K in Q1 2017. 223 funds tracked by Wall St. Rank hold IART as of Q2 2017.

  • Capstone Investment Advisors reported no remaining Integra LifeSciences position as of Q2 2017 after selling out during the quarter.
  • Capstone Investment Advisors sold 12,312 Integra LifeSciences shares in Q2 2017, an estimated $518K.
  • Capstone Investment Advisors first reported a position in Integra LifeSciences in Q2 2016 and held it in 3 quarters.
  • Capstone Investment Advisors's Integra LifeSciences position peaked at $518K in Q1 2017.
  • 223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2017.

Based on Capstone Investment Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.